Institute for Translational Vaccinology:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Institute for Translational Vaccinology - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9434
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Institute for Translational Vaccinology (Intravacc) is a nonprofit research and development organization that concentrates on the development of vaccines. The organization’s services include technology transfer, exploratory and clinical research and regulatory support. It also provides novel research and has various development programs on vaccine delivery and formulation. Intravacc’s research and development programs comprise global health, bacterial and viral vaccines, polio center, animal models and 3R research, and vaccine formulation and delivery. The organization conducts research in various areas such as bacterial vaccine technology, viral vaccine technology, novel vaccines and clinical immunology. The organization works in collaboration with pharmaceutical, biotechnology, governments and public institutions to develop novel vaccines. Intravacc is headquartered in Bilthoven, the Netherlands.

Institute for Translational Vaccinology – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Institute for Translational Vaccinology, Medical Devices Deals, 2012 to YTD 2018 9
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Expres2ion Biotech and Institute for Translational Vaccinology Enter into Agreement 11
Abera Bioscience Enters into Partnership with Institute for Translational Vaccinology 12
Intravacc And MyLife Technologies Enter Into Co-Development Agreement For Intradermal Vaccination Technology 13
Intravacc Partners with International Vaccine Institute 14
Licensing Agreements 15
Sinovac Biotech Enters Into Licensing Agreement With Intravacc For Sabin Inactivated Polio Vaccine 15
Intravacc Enters into Licensing Agreement with Crucell Holland 16
Intravacc Enters into Licensing Agreement with ViciniVax 17
Institute for Translational Vaccinology – Key Competitors 18
Institute for Translational Vaccinology – Key Employees 19
Institute for Translational Vaccinology – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Corporate Communications 21
May 04, 2017: Thijs Veerman CEO at Intravacc 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Key Facts 2
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Institute for Translational Vaccinology, Deals By Therapy Area, 2012 to YTD 2018 8
Institute for Translational Vaccinology, Medical Devices Deals, 2012 to YTD 2018 9
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Expres2ion Biotech and Institute for Translational Vaccinology Enter into Agreement 11
Abera Bioscience Enters into Partnership with Institute for Translational Vaccinology 12
Intravacc And MyLife Technologies Enter Into Co-Development Agreement For Intradermal Vaccination Technology 13
Intravacc Partners with International Vaccine Institute 14
Sinovac Biotech Enters Into Licensing Agreement With Intravacc For Sabin Inactivated Polio Vaccine 15
Intravacc Enters into Licensing Agreement with Crucell Holland 16
Intravacc Enters into Licensing Agreement with ViciniVax 17
Institute for Translational Vaccinology, Key Competitors 18
Institute for Translational Vaccinology, Key Employees 19

List of Figures
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Institute for Translational Vaccinology, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Institute for Translational Vaccinology, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Institute for Translational Vaccinology:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ConocoPhillips (COP):石油・ガス:M&Aディール及び事業提携情報
    Summary ConocoPhillips is an independent upstream oil and gas company. The company explore for, produce, transport and market crude oil, bitumen, natural gas, liquefied natural gas (LNG) and natural gas liquids across the world. It has assets across North America, Europe, Asia and Australia. Its ass …
  • SMART Technologies Inc.:企業の戦略的SWOT分析
    SMART Technologies Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Gardiner & Theobald LLP:企業の戦略的SWOT分析
    Gardiner & Theobald LLP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Guerbet SA (GBT):企業の財務・戦略的SWOT分析
    Guerbet SA (GBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Dollar Tree Inc:企業の戦略・SWOT・財務情報
    Dollar Tree Inc - Strategy, SWOT and Corporate Finance Report Summary Dollar Tree Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • TOR Minerals International Inc (TORM):企業の財務・戦略的SWOT分析
    Summary TOR Minerals International Inc (TOR) is a chemical company that manufactures and distributes mineral and pigment products. The company provides products such as optiload, aluprem, haltex, and others. It also offers alumina trihydrate and boehmite halogen-free flame retardant and smoke suppre …
  • AMAG Pharmaceuticals Inc (AMAG)-医療機器分野:企業M&A・提携分析
    Summary AMAG Pharmaceuticals Inc (AMAG) is a biopharmaceutical company that develops and commercializes specialty pharmaceutical products. The company focuses on maternal health, anemia management and cancer supportive care. Its major products include Makena (hydroxyprogesterone caproate injection) …
  • Valener Inc (VNR)-石油・ガス分野:企業M&A・提携分析
    Summary Valener Inc (Valener) is an investment holding company that focuses on the energy sector. Through its investment companies, the company offers storage, distribution, transportation and allied energy services. The company has interests in Gaz Metro and is its limited partner. Valener, through …
  • Sage Therapeutics Inc (SAGE):製薬・医療:M&Aディール及び事業提携情報
    Summary Sage Therapeutics Inc (Sage) is a clinical-stage biopharmaceutical company that discovers and develops therapeutics and medicines for central nervous system (CNS) disorders. It develops drugs based on selective allosteric modulation of CNS synaptic and extrasynaptic receptors. The company ha …
  • Commercial Bank International PSC:企業の戦略・SWOT・財務情報
    Commercial Bank International PSC - Strategy, SWOT and Corporate Finance Report Summary Commercial Bank International PSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Zimmer Biomet Holdings Inc (ZBH):企業の財務・戦略的SWOT分析
    Zimmer Biomet Holdings Inc (ZBH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Concho Resources Inc (CXO):企業の財務・戦略的SWOT分析
    Summary Concho Resources Inc (Concho) is an oil and gas company. It acquires, develops, produces and explores oil and natural gas properties. The company owns and operates exploration assets in the Permian Basin region of Southeast New Mexico and West Texas, an onshore oil and natural gas basin in t …
  • Owen Mumford Ltd:企業の戦略的SWOT分析
    Owen Mumford Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Laborie Medical Technologies Inc:企業の製品パイプライン分析2018
    Summary Laborie Medical Technologies Inc (Laborie), a subsidiary of Patricia Industries AB, develops and manufactures medical diagnostics and devices. The company offers uroflowmetry, urodynamics, pelvic floor rehabilitation and anorectal manometry products and related consumables. It also provides …
  • Logitech International SA (LOGN):企業の財務・戦略的SWOT分析
    Logitech International SA (LOGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Cooper Tire & Rubber Company:企業の戦略・SWOT・財務情報
    Cooper Tire & Rubber Company - Strategy, SWOT and Corporate Finance Report Summary Cooper Tire & Rubber Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Welltower Inc:企業の戦略・SWOT・財務情報
    Welltower Inc - Strategy, SWOT and Corporate Finance Report Summary Welltower Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Lucigen Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Lucigen Corp (Lucigen), a subsidiary of LGC Ltd, is a medical device company that discovers, manufactures, and commercializes molecular biology product. The company’s products comprise competent cells, nextgen seq, enzymes, cloning systems, PCR and amplification, cloning test kits and vector …
  • Tonix Pharmaceuticals Holding Corp (TNXP):企業の財務・戦略的SWOT分析
    Summary Tonix Pharmaceuticals Holding Corp (Tonix) is a developer of pharmaceutical products to address public health challenges. The company offers pharmaceutical products and treatments for disorders of the central nervous system including fibromyalgia, post traumatic stress disorder and episodic …
  • Osprey Medical Inc (OSP)-医療機器分野:企業M&A・提携分析
    Summary Osprey Medical Inc (Osprey Medical) is a medical device company that designs, develops, and manufacturers proprietary devices and monitoring systems. The company provides contrast removal system, which is designed to provide cardiologists with an advanced level of CIN protection in high risk …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆